{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:29:57Z","timestamp":1762522197578,"version":"3.37.3"},"reference-count":60,"publisher":"American Association for Cancer Research (AACR)","issue":"12","funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute (NCI)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["N02BC71006"],"award-info":[{"award-number":["N02BC71006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p>African Americans (AA) experience higher incidence and mortality of lung cancer as compared with European Americans (EA). Inflammation is associated with lung cancer, many aspects of which differ between AA and EA. We investigated whether use, frequency, and duration of the anti-inflammatory drug aspirin were associated with lung cancer risk and survival, separately among AA and EA populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Using data from the Maryland Non\u2013Small Cell Lung Cancer (NSCLC) Case\u2013Control Study (1,220 cases [404 AA and 816 EA] and 1,634 controls [1,004 EA and 630 AA]), we estimated the adjusted odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) of the associations between aspirin use and NSCLC risk and survival, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Any aspirin use (OR: 0.66; 95% CI, 0.49\u20130.89), daily use of \u2265 1 tablet (OR: 0.68; 95% CI, 0.50\u20130.90), and use for \u2265 3 years (OR: 0.61; 95% CI, 0.44\u20130.85) was associated with lower NSCLC risk only among men, even after adjustment for covariates including body mass index and global genetic ancestry. These variables were also associated with improved survival, but only among AA (HR: 0.64; 95% CI, 0.46\u20130.91; HR: 0.61; 95% CI, 0.42\u20130.90; and HR: 0.60; 95% CI, 0.39\u20130.92, respectively). Tylenol and other NSAIDs were either associated with elevated or no NSCLC risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Aspirin use is associated with lower risk of NSCLC among men and improved survival among AA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Impact:<\/jats:title>\n                  <jats:p>Preventive regular aspirin use could be considered among men and AA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1158\/1055-9965.epi-18-0366","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T14:25:18Z","timestamp":1535725518000},"page":"1518-1526","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Racial and Ethnic Differences in the Relationship between Aspirin Use and Non\u2013Small Cell Lung Cancer Risk and Survival"],"prefix":"10.1158","volume":"27","author":[{"given":"Patricia","family":"Erickson","sequence":"first","affiliation":[{"name":"1George Washington University, Washington, District of Columbia."},{"name":"2Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3340-2818","authenticated-orcid":false,"given":"Lisa D.","family":"Gardner","sequence":"additional","affiliation":[{"name":"3Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Loffredo","sequence":"additional","affiliation":[{"name":"4Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane Marie","family":"St. George","sequence":"additional","affiliation":[{"name":"3Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise D.","family":"Bowman","sequence":"additional","affiliation":[{"name":"2Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaki","family":"Deepak","sequence":"additional","affiliation":[{"name":"5Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-9351","authenticated-orcid":false,"given":"Khadijah","family":"Mitchell","sequence":"additional","affiliation":[{"name":"2Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire L.","family":"Meaney","sequence":"additional","affiliation":[{"name":"2Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Langenberg","sequence":"additional","affiliation":[{"name":"3Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra H.","family":"Bernat","sequence":"additional","affiliation":[{"name":"1George Washington University, Washington, District of Columbia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sania","family":"Amr","sequence":"additional","affiliation":[{"name":"3Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland."},{"name":"6Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Br\u00edd M.","family":"Ryan","sequence":"additional","affiliation":[{"name":"2Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"2022060921103016500_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2022060921103016500_bib2","doi-asserted-by":"crossref","first-page":"e0121323","DOI":"10.1371\/journal.pone.0121323","article-title":"Lung cancer incidence trends by gender, race and histology in the United States, 1973\u20132010","volume":"10","author":"Meza","year":"2015","journal-title":"PLoS One"},{"key":"2022060921103016500_bib3","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(10)62101-0","article-title":"Non-small-cell lung cancer","volume":"378","author":"Goldstraw","year":"2011","journal-title":"Lancet"},{"key":"2022060921103016500_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2014.08.001","article-title":"Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004\u20132009","volume":"86","author":"Houston","year":"2014","journal-title":"Lung Cancer"},{"key":"2022060921103016500_bib5","first-page":"385","article-title":"Lung cancer care: the impact of facilities and area measures","volume":"4","author":"Lathan","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"2022060921103016500_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ncponc0718","article-title":"Lung carcinoma in African Americans","volume":"4","author":"Abidoye","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"2022060921103016500_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1158\/1055-9965.EPI-15-0378","article-title":"Differential serum cytokine levels and risk of lung cancer between African and European Americans","volume":"25","author":"Pine","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060921103016500_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CEJ.0000000000000176","article-title":"Meta-analysis of aspirin use and risk of lung cancer shows notable results","volume":"25","author":"Hochmuth","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"2022060921103016500_bib9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"2022060921103016500_bib10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"2022060921103016500_bib11","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"2022060921103016500_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"2022060921103016500_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.7326\/0003-4819-159-2-201307160-00013","article-title":"Alternate-day, low-dose aspirin and cancer risk","volume":"159","author":"Rothwell","year":"2013","journal-title":"Ann Intern Med"},{"key":"2022060921103016500_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-30331-9_7","article-title":"Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits","volume":"191","author":"Rothwell","year":"2013","journal-title":"Recent Results Cancer Res"},{"key":"2022060921103016500_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pmedr.2016.12.023","article-title":"Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States, 2012-2015","volume":"5","author":"Stuntz","year":"2017","journal-title":"Prev Med Rep"},{"key":"2022060921103016500_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1586\/14737140.8.4.605","article-title":"Inflammation in the development of lung cancer: epidemiological evidence","volume":"8","author":"Engels","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"2022060921103016500_bib17","first-page":"1001","article-title":"Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas","volume":"5","author":"Achiwa","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2022060921103016500_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.med.57.121304.131253","article-title":"NSAIDs and cancer prevention: targets downstream of COX-2","volume":"58","author":"Cha","year":"2007","journal-title":"Annu Rev Med"},{"key":"2022060921103016500_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2008.03.004","article-title":"Pro-inflammatory prostaglandins and progression of colorectal cancer","volume":"267","author":"Wang","year":"2008","journal-title":"Cancer Lett"},{"key":"2022060921103016500_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"2022060921103016500_bib21","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10552-011-9847-z","article-title":"Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)","volume":"22","author":"McCormack","year":"2011","journal-title":"Cancer Causes Control"},{"key":"2022060921103016500_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopha.2013.11.006","article-title":"Aspirin reduces lung cancer metastasis to regional lymph nodes","volume":"68","author":"Ogawa","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"2022060921103016500_bib23","doi-asserted-by":"crossref","first-page":"e0122962","DOI":"10.1371\/journal.pone.0122962","article-title":"Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"2022060921103016500_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1055-9965.EPI-07-0517","article-title":"Regular adult aspirin use decreases the risk of non-small cell lung cancer among women","volume":"17","author":"Van Dyke","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060921103016500_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1378\/chest.127.3.748","article-title":"Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis","volume":"127","author":"Khuder","year":"2005","journal-title":"Chest"},{"key":"2022060921103016500_bib26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/JTO.0b013e3182641bdc","article-title":"Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study","volume":"7","author":"Brasky","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2022060921103016500_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1186\/s12885-015-1910-9","article-title":"Low-dose aspirin and survival from lung cancer: a population-based cohort study","volume":"15","author":"McMenamin","year":"2015","journal-title":"BMC Cancer"},{"key":"2022060921103016500_bib28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1055-9965.EPI-16-1027","article-title":"Aspirin use reduces the risk of aggressive prostate cancer and disease recurrence in African-American men","volume":"26","author":"Smith","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060921103016500_bib29","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-17-0527","article-title":"Comparative transcriptome profiling reveals coding and noncoding RNA differences in NSCLC from African Americans and European Americans","volume":"23","author":"Mitchell","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2022060921103016500_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/1055-9965.EPI-06-0790","article-title":"Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors","volume":"16","author":"Mechanic","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060921103016500_bib31","doi-asserted-by":"crossref","first-page":"e112916","DOI":"10.1371\/journal.pone.0112916","article-title":"Association of genetic ancestry with breast cancer in ethnically diverse women from Chicago","volume":"9","author":"Al-Alem","year":"2014","journal-title":"PLoS One"},{"key":"2022060921103016500_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/humu.20822","article-title":"Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America","volume":"30","author":"Kosoy","year":"2009","journal-title":"Hum Mutat"},{"key":"2022060921103016500_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2156-10-39","article-title":"An ancestry informative marker set for determining continental origin: validation and extension using human genome diversity panels","volume":"10","author":"Nassir","year":"2009","journal-title":"BMC Genet"},{"key":"2022060921103016500_bib34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/genetics\/164.4.1567","article-title":"Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies","volume":"164","author":"Falush","year":"2003","journal-title":"Genetics"},{"key":"2022060921103016500_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2022060921103016500_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/CLEP.S72032","article-title":"Aspirin overutilization for the primary prevention of cardiovascular disease","volume":"6","author":"VanWormer","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2022060921103016500_bib37","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","article-title":"Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"24","author":"Wang","year":"2013","journal-title":"Ann Oncol"},{"key":"2022060921103016500_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2407-2-31","article-title":"Regular aspirin use and lung cancer risk","volume":"2","author":"Moysich","year":"2002","journal-title":"BMC cancer"},{"key":"2022060921103016500_bib39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.lungcan.2012.03.005","article-title":"Aspirin and non-aspirin nonsteroidal anti-inflammatory drug use and risk of lung cancer","volume":"77","author":"Lim","year":"2012","journal-title":"Lung Cancer"},{"key":"2022060921103016500_bib40","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1055-9965.EPI-08-1110","article-title":"Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study","volume":"18","author":"Slatore","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060921103016500_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6604151","article-title":"Use of NSAIDs, smoking and lung cancer risk","volume":"98","author":"Olsen","year":"2008","journal-title":"Br J Cancer"},{"key":"2022060921103016500_bib42","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/cncr.11242","article-title":"Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs","volume":"97","author":"Muscat","year":"2003","journal-title":"Cancer"},{"key":"2022060921103016500_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2022060921103016500_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7150\/ijbs.3.328","article-title":"Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study","volume":"3","author":"Harris","year":"2007","journal-title":"Int J Biol Sci"},{"key":"2022060921103016500_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","article-title":"Aspirin use and lung, colon, and breast cancer incidence in a prospective study","volume":"5","author":"Schreinemachers","year":"1994","journal-title":"Epidemiology"},{"key":"2022060921103016500_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjc.6600370","article-title":"Aspirin and lung cancer in women","volume":"87","author":"Akhmedkhanov","year":"2002","journal-title":"Br J Cancer"},{"key":"2022060921103016500_bib47","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djk132","article-title":"A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence","volume":"99","author":"Jacobs","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2022060921103016500_bib48","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1055-9965.EPI-06-0172","article-title":"Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women's health study","volume":"15","author":"Hayes","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060921103016500_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/pds.1532","article-title":"Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs","volume":"17","author":"Kelly","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022060921103016500_bib50","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.bjc.6603996","article-title":"Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency","volume":"97","author":"Feskanich","year":"2007","journal-title":"Br J Cancer"},{"key":"2022060921103016500_bib51","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.bjc.6601343","article-title":"Aspirin use and lung cancer in men","volume":"89","author":"Holick","year":"2003","journal-title":"Br J Cancer"},{"key":"2022060921103016500_bib52","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2014.58.9952","article-title":"Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: a prospective investigation in the CAPP2 Study","volume":"33","author":"Movahedi","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022060921103016500_bib53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10552-006-0075-x","article-title":"Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States)","volume":"17","author":"Kim","year":"2006","journal-title":"Cancer Causes Control"},{"key":"2022060921103016500_bib54","first-page":"3177","article-title":"Aspirin use and mortality from cancer in a prospective cohort study","volume":"24","author":"Ratnasinghe","year":"2004","journal-title":"Anticancer Res"},{"key":"2022060921103016500_bib55","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.annepidem.2018.04.012","article-title":"Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race","volume":"28","author":"Gardner","year":"2018","journal-title":"Ann Epidemiol"},{"key":"2022060921103016500_bib56","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1038\/emm.2015.96","article-title":"Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease","volume":"48","author":"Kong","year":"2016","journal-title":"Exp Mol Med"},{"key":"2022060921103016500_bib57","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbrc.2006.03.073","article-title":"IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer","volume":"343","author":"Cui","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2022060921103016500_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajhg.2014.11.010","article-title":"The genetic ancestry of African Americans, Latinos, and European Americans across the United States","volume":"96","author":"Bryc","year":"2015","journal-title":"Am J Hum Genet"},{"key":"2022060921103016500_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-014-0023-x","article-title":"Self-reported race\/ethnicity in the age of genomic research: its potential impact on understanding health disparities","volume":"9","author":"Mersha","year":"2015","journal-title":"Hum Genomics"},{"key":"2022060921103016500_bib60","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/jnci\/djt331","article-title":"Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations","volume":"105","author":"Nan","year":"2013","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Epidemiology, Biomarkers &amp; Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/27\/12\/1518\/2284348\/1518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/27\/12\/1518\/2284348\/1518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T02:28:36Z","timestamp":1654828116000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cebp\/article\/27\/12\/1518\/71585\/Racial-and-Ethnic-Differences-in-the-Relationship"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,3]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1055-9965.epi-18-0366","relation":{},"ISSN":["1055-9965","1538-7755"],"issn-type":[{"type":"print","value":"1055-9965"},{"type":"electronic","value":"1538-7755"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}